155 related articles for article (PubMed ID: 31874794)
1. Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) Experience.
Sobas M; Czyż A; Montesinos P; Armatys A; Helbig G; Hołowiecka A; Pluta A; Zarzycka E; Piątkowska-Jakubas B; Majcherek M; Lewandowski K; Gołos A; Paluszewska M; Podhorecka M; Oleksiuk J; Skręt A; Hawrylecka D; Guzicka-Kazimierczak RE; Wątek M; Gromek T; Charliński G; Grosicki S; Holojda J; Miśkiewicz W; Martinez-Cuadrón D; Sanz MA; Wróbel T; Wierzbowska A; Giebel S
Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):105-113. PubMed ID: 31874794
[TBL] [Abstract][Full Text] [Related]
2. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.
de la Serna J; Montesinos P; Vellenga E; Rayón C; Parody R; León A; Esteve J; Bergua JM; Milone G; Debén G; Rivas C; González M; Tormo M; Díaz-Mediavilla J; González JD; Negri S; Amutio E; Brunet S; Lowenberg B; Sanz MA
Blood; 2008 Apr; 111(7):3395-402. PubMed ID: 18195095
[TBL] [Abstract][Full Text] [Related]
3. Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience.
Akcay OF; Yeter HH; Buyukasik Y
Rom J Intern Med; 2020 Sep; 58(3):138-145. PubMed ID: 32452194
[TBL] [Abstract][Full Text] [Related]
4. The global problem of early deaths in acute promyelocytic leukemia: A strategy to decrease induction mortality in the most curable leukemia.
Jillella AP; Kota VK
Blood Rev; 2018 Mar; 32(2):89-95. PubMed ID: 29033137
[TBL] [Abstract][Full Text] [Related]
5. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
Zhu HH; Wu DP; Du X; Zhang X; Liu L; Ma J; Shao ZH; Ren HY; Hu JD; Xu KL; Wang JW; Song YP; Fang MY; Li J; Yan XY; Huang XJ
Lancet Oncol; 2018 Jul; 19(7):871-879. PubMed ID: 29884593
[TBL] [Abstract][Full Text] [Related]
6. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
[TBL] [Abstract][Full Text] [Related]
7. Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience.
Pulsoni A; Pagano L; Lo Coco F; Avvisati G; Mele L; Di Bona E; Invernizzi R; Leoni F; Marmont F; Mele A; Melillo L; Nosari AM; Pogliani EM; Vignetti M; Visani G; Zagonel V; Leone G; Mandelli F
Blood; 2002 Sep; 100(6):1972-6. PubMed ID: 12200354
[TBL] [Abstract][Full Text] [Related]
8. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.
Sanz MA; Montesinos P; Kim HT; Ruiz-Argüelles GJ; Undurraga MS; Uriarte MR; Martínez L; Jacomo RH; Gutiérrez-Aguirre H; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Vellenga E; Holowiecka A; González-Huerta AJ; Fernández P; De la Serna J; Brunet S; De Lisa E; González-Campos J; Ribera JM; Krsnik I; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Rego EM;
Ann Hematol; 2015 Aug; 94(8):1347-56. PubMed ID: 25975975
[TBL] [Abstract][Full Text] [Related]
9. Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia.
Zhao H; Zhao Y; Zhang Y; Hou J; Yang H; Cao F; Yang Y; Hou W; Sun J; Jin B; Fu J; Li H; Wang P; Ge F; Zhou J
Ann Hematol; 2018 Mar; 97(3):409-416. PubMed ID: 29289982
[TBL] [Abstract][Full Text] [Related]
10. Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.
Lengfelder E; Görlich D; Nowak D; Spiekermann K; Haferlach C; Krug U; Kreuzer KA; Braess J; Schliemann C; Lindemann HW; Horst HA; Schiel X; Flasshove M; Hecht A; Schnittger S; Schneider S; Wörmann B; Hofmann WK; Berdel WE; Bormann E; Sauerland C; Büchner T; Hiddemann W;
Eur J Haematol; 2018 Feb; 100(2):154-162. PubMed ID: 29114972
[TBL] [Abstract][Full Text] [Related]
11. Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy.
Abla O; Ribeiro RC; Testi AM; Montesinos P; Creutzig U; Sung L; Di Giuseppe G; Stephens D; Feusner JH; Powell BL; Hasle H; Kaspers GJL; Dalla-Pozza L; Lassaletta A; Tallman MS; Locatelli F; Reinhardt D; Lo-Coco F; Hitzler J; Sanz MA
Ann Hematol; 2017 Sep; 96(9):1449-1456. PubMed ID: 28597167
[TBL] [Abstract][Full Text] [Related]
12. Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia.
Minamiguchi H; Fujita H; Atsuta Y; Asou N; Sakura T; Ueda Y; Sawa M; Dobashi N; Taniguchi Y; Suzuki R; Uchino Y; Tomita A; Tamaki S; Hagihara M; Fujimaki K; Yanada M; Maeda Y; Iwanaga M; Usui N; Kobayashi Y; Ohtake S; Kiyoi H; Matsumura I; Miyazaki Y; Naoe T; Takeshita A;
Ann Hematol; 2020 Dec; 99(12):2787-2800. PubMed ID: 32879992
[TBL] [Abstract][Full Text] [Related]
13. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
14. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group.
Kanamaru A; Takemoto Y; Tanimoto M; Murakami H; Asou N; Kobayashi T; Kuriyama K; Ohmoto E; Sakamaki H; Tsubaki K
Blood; 1995 Mar; 85(5):1202-6. PubMed ID: 7858250
[TBL] [Abstract][Full Text] [Related]
15. PLZF-RAR
Sobas M; Talarn-Forcadell MC; Martínez-Cuadrón D; Escoda L; García-Pérez MJ; Mariz J; Mela-Osorio MJ; Fernández I; Alonso-Domínguez JM; Cornago-Navascués J; Rodríguez-Macias G; Amutio ME; Rodríguez-Medina C; Esteve J; Sokół A; Murciano-Carrillo T; Calasanz MJ; Barrios M; Barragán E; Sanz MA; Montesinos P
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455804
[TBL] [Abstract][Full Text] [Related]
16. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
De Botton S; Dombret H; Sanz M; Miguel JS; Caillot D; Zittoun R; Gardembas M; Stamatoulas A; Condé E; Guerci A; Gardin C; Geiser K; Makhoul DC; Reman O; de la Serna J; Lefrere F; Chomienne C; Chastang C; Degos L; Fenaux P
Blood; 1998 Oct; 92(8):2712-8. PubMed ID: 9763554
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy.
Martínez-Cuadrón D; Montesinos P; Vellenga E; Bernal T; Salamero O; Holowiecka A; Brunet S; Gil C; Benavente C; Ribera JM; Pérez-Encinas M; De la Serna J; Esteve J; Rubio V; González-Campos J; Escoda L; Amutio ME; Arnan M; Arias J; Negri S; Lowënberg B; Sanz MA
Leukemia; 2018 Jan; 32(1):21-29. PubMed ID: 28584252
[TBL] [Abstract][Full Text] [Related]
18. Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience.
Sobas M; Knopinska-Posluszny W; Piątkowska-Jakubas B; García-Álvarez F; Díez MEA; Caballero M; Martínez-Cuadrón D; Aguiar E; González-Campos J; Garrido A; Algarra L; Salamero O; de la Serna J; Sayas MJ; Perez-Encinas MM; Vives S; Vidriales B; Labrador J; Prado AI; Celebrin L; Mayer J; Brioso J; de Laiglesia A; Bergua JM; Amigo ML; Rodriguez-Medina C; Polo M; Pluta A; Cichocka E; Skarupski M; Sanz MA; Wierzbowska A; Montesinos P
Ann Hematol; 2024 Feb; 103(2):451-461. PubMed ID: 38110588
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of causes and predictors of early death in elderly and young patients with acute promyelocytic leukemia treated with arsenic trioxide.
Jin B; Zhang Y; Hou W; Cao F; Lu M; Yang H; Tian X; Wang Y; Hou J; Fu J; Li H; Zhou J
J Cancer Res Clin Oncol; 2020 Feb; 146(2):485-492. PubMed ID: 31686248
[TBL] [Abstract][Full Text] [Related]
20. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
Raza S; Ullah K; Ahmed P; Khan B
J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
